TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?

TICO study: ASA-free antiplatelet therapy after coronary intervention for acute coronary syndrome—is ticagrelor monotherapy the solution?

This is a preview of subscription content, log in to check access.

Literatur

  1. 1.

    Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L Bhatt, Paul Dendale, Maria Dorobantu, Thor Edvardsen, Thierry Folliguet, Chris P Gale, Martine Gilard, Alexander Jobs, Peter Jüni, Ekaterini Lambrinou, Basil S Lewis, Julinda Mehilli, Emanuele Meliga, Béla Merkely, Christian Mueller, Marco Roffi, Frans H Rutten, Dirk Sibbing, George C M Siontis, ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2020 Aug 29;ehaa575. https://doi.org/10.1093/eurheartj/ehaa575. Online im Druck.

  2. 2.

    Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Džavík V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM (2019) Ticagrelor with or without Aspirin in High-Risk Patients after PCI. n Engl J Med 21;381(21):2032–2042 (Nov)

    Article  Google Scholar 

  3. 3.

    Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S, GLOBAL LEADERS Investigators. (2018) Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 15;392(10151):940–949 (Sep)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Prof. Dr. Holger Eggebrecht.

Ethics declarations

Interessenkonflikt

H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eggebrecht, H. TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?. Kardiologe (2020). https://doi.org/10.1007/s12181-020-00427-8

Download citation